APA (7th ed.) Citation

L, G., S, B., M, S., P, G., C, L. P., F, G., . . . P, K. (2016). GEP analysis validates high risk MDS and acute myeloid leukemia post MDS mice models and highlights novel dysregulated pathways. Journal of hematology & oncology, 9, 5. https://doi.org/10.1186/s13045-016-0235-8

Chicago Style (17th ed.) Citation

L, Guerenne, et al. "GEP Analysis Validates High Risk MDS and Acute Myeloid Leukemia Post MDS Mice Models and Highlights Novel Dysregulated Pathways." Journal of Hematology & Oncology 9 (2016): 5. https://doi.org/10.1186/s13045-016-0235-8.

MLA (9th ed.) Citation

L, Guerenne, et al. "GEP Analysis Validates High Risk MDS and Acute Myeloid Leukemia Post MDS Mice Models and Highlights Novel Dysregulated Pathways." Journal of Hematology & Oncology, vol. 9, 2016, p. 5, https://doi.org/10.1186/s13045-016-0235-8.